关注
Shanta Alli
Shanta Alli
Department of Immunology, St. Jude Children's Research Hospital
在 stjude.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity
B Prinzing, CC Zebley, CT Petersen, Y Fan, AA Anido, Z Yi, P Nguyen, ...
Science translational medicine 13 (620), eabh0272, 2021
1762021
Elimination of huntingtin in the adult mouse leads to progressive behavioral deficits, bilateral thalamic calcification, and altered brain iron homeostasis
P Dietrich, IM Johnson, S Alli, I Dragatsis
PLoS genetics 13 (7), e1006846, 2017
962017
Beta cell-specific CD8+ T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetes
HA Abdelsamed, CC Zebley, H Nguyen, RL Rutishauser, Y Fan, ...
Nature immunology 21 (5), 578-587, 2020
862020
CD19-CAR T cells undergo exhaustion DNA methylation programming in patients with acute lymphoblastic leukemia
CC Zebley, C Brown, T Mi, Y Fan, S Alli, S Boi, G Galletti, E Lugli, ...
Cell reports 37 (9), 2021
612021
IKAP expression levels modulate disease severity in a mouse model of familial dysautonomia
P Dietrich, S Alli, R Shanmugasundaram, I Dragatsis
Human molecular genetics 21 (23), 5078-5090, 2012
572012
Adipose stem cells and their paracrine factors are therapeutic for early retinal complications of diabetes in the Ins2Akita mouse
SL Elshaer, W Evans, M Pentecost, R Lenin, R Periasamy, KA Jha, S Alli, ...
Stem Cell Research & Therapy 9, 1-18, 2018
492018
Sensory and autonomic deficits in a new humanized mouse model of familial dysautonomia
E Morini, P Dietrich, M Salani, HM Downs, GR Wojtkiewicz, S Alli, ...
Human Molecular Genetics 25 (6), 1116-1128, 2016
422016
Proinflammatory cytokines promote TET2-mediated DNA demethylation during CD8 T cell effector differentiation
CC Zebley, HA Abdelsamed, HE Ghoneim, S Alli, C Brown, D Haydar, ...
Cell reports 37 (2), 2021
232021
Critical role of endoplasmic reticulum stress in chronic endothelial activation− induced visual deficits in tie2‐tumor necrosis factor mice
R Lenin, PG Nagy, S Alli, VR Rao, MA Clauss, UB Kompella, R Gangaraju
Journal of cellular biochemistry 119 (10), 8460-8471, 2018
202018
Prevention and treatment of secretory diarrhea by the lysophosphatidic acid analog Rx100
KE Thompson, RM Ray, S Alli, W Ge, A Boler, W Shannon McCool, ...
Experimental Biology and Medicine 243 (13), 1056-1065, 2018
122018
Identification of cyclin D1 as a major modulator of 3-nitropropionic acid-induced striatal neurodegeneration
P Dietrich, S Alli, MK Mulligan, R Cox, DG Ashbrook, RW Williams, ...
Neurobiology of disease 162, 105581, 2022
112022
Antigen cross-presentation in young tumor-bearing hosts promotes CD8+ T cell terminal differentiation
A Moustaki, JC Crawford, S Alli, Y Fan, S Boi, AE Zamora, ...
Science immunology 7 (68), eabf6136, 2022
82022
Antitumor progenitor exhausted CD8+ T cells are sustained by TCR engagement
X Lan, T Mi, S Alli, C Guy, MN Djekidel, X Liu, S Boi, P Chowdhury, M He, ...
Nature Immunology, 1-13, 2024
22024
Conserved epigenetic hallmarks of T cell aging during immunity and malignancy
T Mi, AG Soerens, S Alli, TG Kang, AB Vasandan, Z Wang, V Vezys, ...
Nature Aging, 1-11, 2024
12024
ASXL1 disruption preserves CD8 T cell exhaustion-progenitor epigenetic programming during chronic stimulation
TG Kang, X Lan, S Alli, CL O’Connell, K Gronbaek, P Jones, JH Han, ...
The Journal of Immunology 210 (1_Supplement), 226.10-226.10, 2023
12023
IL-12 signaling promotes TET2-mediated DNA demethylation during CD8 T cell effector differentiation
CC Zebley, HA Abdelsamed, HE Ghoneim, S Alli, D Haydar, T Harris, ...
bioRxiv, 2020.11. 02.365148, 2020
12020
1516 Advancing immunotherapy through patient-identified regulators of T cell stemness
C Zebley, TG Kang, T Mi, S Alli, G Ward, AB Vasandan, S Carson, X Lan, ...
Journal for ImmunoTherapy of Cancer 11 (Suppl 2), 2023
2023
Conserved epigenetic hallmarks of T-cell age
CC Zebley, T Mi, A Soerens, S Alli, A Vasandan, C Hines, A Mueller, ...
The Journal of Immunology 210 (1_Supplement), 148.07-148.07, 2023
2023
YIA23-001: Targeting NKG2D Ligands Is Therapeutically Effective in NSCLC
Q Deng, MJ Lee, F Fattah, S Koyama, D Gerber, E Akbay
Journal of the National Comprehensive Cancer Network 21 (3.5), YIA23-001 …, 2023
2023
YIA23-003: CD19-CAR T Cells Develop Exhaustion Epigenetic Programs During a Clinical Response
C Zebley, CC Brown, T Mi, Y Fan, S Alli, S Boi, G Galletti, E Lugli, ...
Journal of the National Comprehensive Cancer Network 21 (3.5), YIA23-003 …, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–20